Invention Grant
- Patent Title: S1P3 antagonists
-
Application No.: US15100326Application Date: 2014-11-28
-
Publication No.: US09951017B2Publication Date: 2018-04-24
- Inventor: Chiara Caramelli , Cesare Federico , Emanuele Gabellieri , Matteo Magnani , Iolanda Micco , Georg C Terstappen
- Applicant: Teva Pharmaceutical Industries Limited
- Applicant Address: IL Petach Tikva
- Assignee: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Current Assignee: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Current Assignee Address: IL Petach Tikva
- Agency: Cooper & Dunham LLP
- Agent John P. White
- Priority: EP13195372 20131202
- International Application: PCT/EP2014/075986 WO 20141128
- International Announcement: WO2015/082357 WO 20150611
- Main IPC: C07D213/75
- IPC: C07D213/75 ; C07D403/12 ; C07D401/12 ; C07D413/12 ; C07D417/12 ; C07D241/16 ; C07D277/32 ; C07D401/14 ; C07D405/14 ; C07D417/14
Abstract:
The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.
Public/Granted literature
- US20160297762A1 S1P3 ANTAGONISTS Public/Granted day:2016-10-13
Information query
IPC分类:
